FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978895912> ?p ?o ?g. }

• W1978895912 endingPage "1149" @default.
• W1978895912 startingPage "1131" @default.
• W1978895912 abstract "medication, but he required medication thereafter. He had no episodes of peritonitis and gained 5 kg. However, his urine output gradually declined despite large doses of furosemide. At the beginning of the third year, despite an increasing dose and number of antihypertensive medications, he complained of progressive fatigue, anorexia, and ankle swelling. He was hypertensive (blood pressure, 180/100 mm Hg), and his urine output was negligible. His serum albumin had decreased to 3.0 g/dl, the blood urea had decreased to 12 mm/liter, and the serum creatinine was 1100 mm/liter (12.5 mg/dl). On repeat assessment, his clearances were KT/V, 1.55 (1.45 peritoneal and 0.1 renal), and WCC, 48 liters (42 liters peritoneal and 6 liters renal). His NPNA had decreased to 0.65 g/kg/day. His weight had increased by 3 kg and he was edematous. His CAPD prescription was increased to 2.5 liters 4 times daily, after which his KT/V increased to 1.75 (1.65 peritoneal CASE PRESENTATION and 0.1 renal) and his weekly creatinine clearance to 58 liters A 55-year-old Greek Canadian, a restaurant owner, devel(52 liters peritoneal and 6 liters renal). After 3 months, his oped end-stage renal disease secondary to proliferative glomerNPNA remained low at 0.60 g/kg/day. His uremic symptoms ulonephritis of 3 years’ duration. Because he was fatigued, had and hypertension became worse, and he could not achieve a poor appetite with occasional morning nausea, and could not his target weight despite three hypertonic exchanges per day. sleep well, he began continuous ambulatory peritoneal dialysis Average ultrafiltration with 2.5% glucose at four hours was 25 (CAPD) 5 years ago through a surgically implanted Toronto ml, and with 4.25% glucose was 180 ml. Dialysate protein losses Western peritoneal catheter. At that time his weight was 71 kg were 12 g/day and his serum albumin fell to 2.8 g/dl. Because his and body surface area 1.76 m. He had substantial residual renal condition was getting worse, he was transferred to automated function, with a 24-hour creatinine clearance of 9.0 ml/min, a peritoneal dialysis (APD) with 4 3 2.8 liter exchange over nine urea clearance of 4.3 ml/min, and a urine volume of 1100 ml/ hours each night and a three-hour 2.5 liter exchange each day. Initial biochemical investigations showed a serum albumin evening. of 3.5 g/dl (Bromcresol green method); hemoglobin, 10.1 g/dl; On this regimen, his KT/V was 2.1 and creatinine clearance and hematocrit, 33%. He was started on a “standard” CAPD 60 liters/week. Furthermore, his net ultrafiltration increased, regimen of 2-liter exchanges four times daily. At the end of he attained his target weight and, after six months, his NPNA the second week, clearance measurements with the Adequestt had increased to 0.8 g/kg/day, but his serum albumin remained program were as follows: D/P creatinine, 0.85; KT/V (urea), low at 3.1 g/dl. Clinically he felt better. He was able to sleep 2.57 (1.07 renal and 1.5 peritoneal); weekly creatinine clearance well and he resumed working part-time work in his restaurant. (WCC) corrected for 1.73 m BSA, 113 liters (65 liters renal Three months later he received a successful transplant with a and 48 liters peritoneal); and normalized equivalent of protein cadaveric kidney. nitrogen appearance (NPNA), 0.8 g/kg/day. The blood urea was 20 mm/liter; serum creatinine, 416 mm/liter (4.7 mg/dl); and blood pressure, 150/80 mm Hg. DISCUSSION For the next two years he did well on CAPD. He felt well and continued working in his restaurant. His appetite was good, Dr. Dimitrios G. Oreopoulos (Director, Peritoneal he slept well, and he had an active sexual life. For the first Dialysis Program, The Toronto Hospital—Western Diviyear, his blood pressure was normal without antihypertensive sion, and Professor of Medicine, University of Toronto, Toronto, Ontario, Canada): A Nephrology Forum given in 1983 by Dr. Stephen Vas [1] was devoted to the diagPresentation of this Forum is made possible by grants from Merck & Company, Incorporated; Astra Pharmaceuticals; Hoechst Marion nosis and treatment of peritonitis—at that time, the main Roussel, Incorporated; Dialysis Clinic, Incorporated; and R & D Labocomplication of CAPD. Since then, the introduction of ratories, Incorporated. several disconnect systems has decreased the rate of peri" @default.
• W1978895912 created "2016-06-24" @default.
• W1978895912 creator A5087812904 @default.
• W1978895912 date "1999-03-01" @default.
• W1978895912 modified "2023-10-12" @default.
• W1978895912 title "The optimization of continuous ambulatory peritoneal dialysis" @default.
• W1978895912 cites W1228079092 @default.
• W1978895912 cites W162905861 @default.
• W1978895912 cites W1653629289 @default.
• W1978895912 cites W1826703760 @default.
• W1978895912 cites W1852565430 @default.
• W1978895912 cites W1876576391 @default.
• W1978895912 cites W1899442605 @default.
• W1978895912 cites W1902719690 @default.
• W1978895912 cites W1908797241 @default.
• W1978895912 cites W1926522849 @default.
• W1978895912 cites W1937115497 @default.
• W1978895912 cites W1948689769 @default.
• W1978895912 cites W1969083191 @default.
• W1978895912 cites W1969420055 @default.
• W1978895912 cites W1970008507 @default.
• W1978895912 cites W1971979157 @default.
• W1978895912 cites W1995215635 @default.
• W1978895912 cites W1995967002 @default.
• W1978895912 cites W1999904465 @default.
• W1978895912 cites W2003036911 @default.
• W1978895912 cites W2008266667 @default.
• W1978895912 cites W2009985073 @default.
• W1978895912 cites W2013261295 @default.
• W1978895912 cites W2013286421 @default.
• W1978895912 cites W2026031926 @default.
• W1978895912 cites W2032351422 @default.
• W1978895912 cites W2041876138 @default.
• W1978895912 cites W2054361787 @default.
• W1978895912 cites W2054960093 @default.
• W1978895912 cites W2061331772 @default.
• W1978895912 cites W2062836080 @default.
• W1978895912 cites W2066809553 @default.
• W1978895912 cites W207408070 @default.
• W1978895912 cites W2075693427 @default.
• W1978895912 cites W2080018492 @default.
• W1978895912 cites W2091683324 @default.
• W1978895912 cites W2092871815 @default.
• W1978895912 cites W2093331434 @default.
• W1978895912 cites W2097109426 @default.
• W1978895912 cites W2097335942 @default.
• W1978895912 cites W2098892086 @default.
• W1978895912 cites W2104720688 @default.
• W1978895912 cites W2106399549 @default.
• W1978895912 cites W2106782507 @default.
• W1978895912 cites W2107467372 @default.
• W1978895912 cites W2121035121 @default.
• W1978895912 cites W2127298405 @default.
• W1978895912 cites W2128416969 @default.
• W1978895912 cites W2136190544 @default.
• W1978895912 cites W2137876214 @default.
• W1978895912 cites W2181315305 @default.
• W1978895912 cites W2187332045 @default.
• W1978895912 cites W2187784926 @default.
• W1978895912 cites W2208506536 @default.
• W1978895912 cites W2208620607 @default.
• W1978895912 cites W2240727449 @default.
• W1978895912 cites W2246464329 @default.
• W1978895912 cites W2256923819 @default.
• W1978895912 cites W2309736365 @default.
• W1978895912 cites W2309933800 @default.
• W1978895912 cites W2333311153 @default.
• W1978895912 cites W2339111887 @default.
• W1978895912 cites W2398074201 @default.
• W1978895912 cites W2399321000 @default.
• W1978895912 cites W2402333110 @default.
• W1978895912 cites W2407087575 @default.
• W1978895912 cites W2408851295 @default.
• W1978895912 cites W2409715104 @default.
• W1978895912 cites W2411846357 @default.
• W1978895912 cites W2415581083 @default.
• W1978895912 cites W2416198118 @default.
• W1978895912 cites W2417256339 @default.
• W1978895912 cites W2420284745 @default.
• W1978895912 cites W2420544685 @default.
• W1978895912 cites W2423228405 @default.
• W1978895912 cites W2431014748 @default.
• W1978895912 cites W2438005830 @default.
• W1978895912 cites W2442393173 @default.
• W1978895912 cites W2465159452 @default.
• W1978895912 cites W2472126195 @default.
• W1978895912 cites W56303912 @default.
• W1978895912 cites W92015550 @default.
• W1978895912 cites W94366506 @default.
• W1978895912 cites W2435875719 @default.
• W1978895912 doi "https://doi.org/10.1046/j.1523-1755.1999.0550031131.x" @default.
• W1978895912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10027956" @default.
• W1978895912 hasPublicationYear "1999" @default.
• W1978895912 type Work @default.
• W1978895912 sameAs 1978895912 @default.
• W1978895912 citedByCount "28" @default.
• W1978895912 countsByYear W19788959122012 @default.
• W1978895912 countsByYear W19788959122013 @default.

• next